Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120.
about
A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Targeting the tumor microenvironment with anti-neu/anti-CD40 conjugated nanoparticles for the induction of antitumor immune responses.Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.Modulation of gene expression related to Toll-like receptor signaling in dendritic cells by poly(gamma-glutamic acid) nanoparticlesApplication of nanotechnologies for improved immune response against infectious diseases in the developing worldUsing carbon magnetic nanoparticles to target, track, and manipulate dendritic cellsPolylactide-cyclosporin A nanoparticles for targeted immunosuppression.Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen.Induction of potent adaptive immunity by the novel polyion complex nanoparticles.Design opportunities for actively targeted nanoparticle vaccines.Potential of polymeric nanoparticles in AIDS treatment and prevention.Small Wonders-The Use of Nanoparticles for Delivering Antigen.Design of nanomaterial based systems for novel vaccine development.Uptake of biodegradable poly(γ-glutamic acid) nanoparticles and antigen presentation by dendritic cells in vivopH-dependent disruption of erythrocyte membrane by amphiphilic poly(amino acid) nanoparticles.Particulate transepithelial drug carriers: barriers and functional polymersNanoparticle Vaccines Against Infectious Diseases
P2860
Q30431343-DACCC0D4-8AAE-41E6-9207-FAD48F28306DQ33611645-FA873749-9395-4463-9B85-F1E313A0B272Q33624332-69023102-FB31-47E9-A9E7-52C88907B568Q33819656-C9B7CA91-8F97-4E37-8C55-540851A1B34FQ33825688-599DC799-7214-42AE-A0B9-88390003ECF1Q33894321-418891EA-A87B-4C53-B285-0D526BBC5392Q34121001-F4E364A4-278A-4E1C-B173-82CBA4CCF8E6Q34378940-87399CE8-2EEA-49F3-8595-C1446BE9B213Q34993838-32D4D6F4-A10D-4C51-9FD1-A9311E288850Q35548034-1B743A6E-DEA4-4E9E-B7E5-3D1301C06019Q37062606-93B354CF-0052-4C1A-AE02-4BA7B3328507Q37818325-B1DE94DE-B4E9-4614-B772-53620C4D9F0DQ38583148-C1679A4E-05F3-48D0-ABCC-84FAF3DDBD1FQ38739675-F38747A8-509E-4F70-926E-C85D0B74BB90Q41902914-7BEA1B82-506F-479A-B039-BC75CD5190E6Q52598785-A3C0E19E-D3B6-4D49-BAEC-F5DF7C17A540Q58385253-019EAB1C-F0E7-4372-BA0D-BB099CF63B16Q58583890-3E20E562-2438-4B72-8ECB-8E7B80742C78
P2860
Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Induction of potent CD8+ T-cel ...... deficiency virus type 1 gp120.
@ast
Induction of potent CD8+ T-cel ...... deficiency virus type 1 gp120.
@en
type
label
Induction of potent CD8+ T-cel ...... deficiency virus type 1 gp120.
@ast
Induction of potent CD8+ T-cel ...... deficiency virus type 1 gp120.
@en
prefLabel
Induction of potent CD8+ T-cel ...... deficiency virus type 1 gp120.
@ast
Induction of potent CD8+ T-cel ...... deficiency virus type 1 gp120.
@en
P2093
P2860
P356
P1433
P1476
Induction of potent CD8+ T-cel ...... deficiency virus type 1 gp120.
@en
P2093
Masanori Baba
Mitsuru Akashi
Takami Akagi
Tomofumi Uto
P2860
P304
10009-10016
P356
10.1128/JVI.00489-07
P407
P577
2007-07-03T00:00:00Z